Phase 1 Behaviour Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Completed
Phase 1
Staff as Change Agents – Sustaining Mental Health in Aged Care
Staff knowledge and skills to manage mental health protocols associated with depression and challenging behaviours associated with dementiaStaff factors such as stress, job satisfaction and staff turnoverPreventative and screening interventions of depression+2 more
Professor Marita McCabe468 enrolled1 locationACTRN12613000420741
Recruiting
Phase 1
A study on the satiety effect of Caralluma fimbriata extract for people with Prader - Willi syndrome (PWS).”
Prader-Willi syndrome (PWS) PWS is caused by three types of abnormality in chromosome 15 at a prevalence rate of 1:11,000 to 1:22,000. The defining feature of PWS is food-seeking behaviour due to constant hunger. Hyperphagia and obesity are one of the main burdens in PWS and obesity is linked to increased morbidity and mortality.
Victoria University16 enrolled1 locationACTRN12611000334909
Not Yet Recruiting
Phase 1
A comparison of intensive individualised behavioural support and traditional medical treatment for the behavioural and psychological symptoms of dementia (BPSD).
The behavioural and psychological symptoms of dementia (BPSD)
Dr Kuruvilla George, Consultant Psychiatrist and Director, Eastern Health's Aged Persons Mental Health Service90 enrolledACTRN12607000344493